Cargando…
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
BACKGROUND: Our previous study of pulmonary function in 34 patients with early breast cancer without preexisting lung disease showed that anthracycline- and taxane-based adjuvant dose-dense chemotherapy (DDC) caused a significant 16.4% mean reduction in carbon monoxide diffusing capacity (DLCO). The...
Autores principales: | Landman, Yosef, Stemmer, Salomon Marcello, Sulkes, Aaron, Neiman, Victoria, Granot, Tal, Hendler, Daniel, Kramer, Mordechai Reuven, Gelmon, Karen, Yerushalmi, Rinat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854974/ https://www.ncbi.nlm.nih.gov/pubmed/31772578 http://dx.doi.org/10.1155/2019/2584859 |
Ejemplares similares
-
Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis
por: Yerushalmi, Rinat, et al.
Publicado: (2014) -
The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics
por: Goldvaser, Hadar, et al.
Publicado: (2016) -
The association between smoking and breast cancer characteristics and outcome
por: Goldvaser, Hadar, et al.
Publicado: (2017) -
Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
por: Ben-Aharon, Irit, et al.
Publicado: (2013) -
Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
por: Levi, Mattan, et al.
Publicado: (2020)